Related Experiment Videos
Osteogenesis imperfecta: bone turnover, bone density, and ultrasound parameters
C Cepollaro1, S Gonnelli, C Pondrelli
1Institute of Internal Medicine, University of Siena, Viale Bracci 2, Siena Italy.
Calcified Tissue International
|August 3, 1999
Summary
Osteogenesis imperfecta (OI) patients exhibit reduced bone mineral density and ultrasound parameters, indicating compromised bone quality. Reduced type I procollagen carboxy-terminal propeptide (PICP) levels suggest collagen I biosynthesis defects, highlighting PICP
Area of Science:
- Biochemistry
- Orthopedics
- Genetics
Background:
- Osteogenesis imperfecta (OI) is a group of genetic disorders characterized by bone fragility.
- Bone metabolism is often altered in OI patients, but comprehensive marker analysis is needed.
Purpose of the Study:
- To evaluate bone mineral density (BMD), ultrasound parameters, and bone turnover markers in OI patients.
- To investigate the relationship between these parameters and collagen I biosynthesis.
Main Methods:
- Studied 21 OI patients and 21 controls, measuring serum ALP, PICP, osteocalcin, urinary hydroxyproline/creatinine, and pyridinoline crosslinks/creatinine.
- Assessed BMD at the radius and lumbar spine using DXA.
- Measured ultrasound parameters at the calcaneus and phalanges.
Main Results:
- OI patients showed significantly reduced BMD and ultrasound parameters compared to controls (P < 0.001).
- Serum PICP levels were significantly lower in OI patients (P < 0.001).
- Other bone turnover markers were elevated but not statistically significant; PICP correlated with BMD and ultrasound parameters.
Conclusions:
- OI patients have disturbed bone mass and quality, evidenced by low BMD and ultrasound values.
- Reduced PICP levels confirm defects in collagen I biosynthesis, contributing to bone fragility.
- PICP is a potentially useful marker for clinical management of OI.